Get started
Author

Meylán Cepeda

Observed names: Cepeda Meylan, M Cepeda, M. Cepeda, Meylan Cepeda, Meylan Cepeda Portales, Meylán Cepeda Portales
ORCID: 0000-0002-7408-9939
Observed ORCID: 0000-0002-7408-9939
OpenAlex ID: A5102726580
A Randomized, Multicenter, Placebo-Controlled Clinical Trial of Racotumomab-Alum Vaccine as Switch Maintenance Therapy in Advanced Non–Small Cell Lung Cancer Patients
2014 · Sailyn Alfonso, Anet Valdés-Zayas, et al. · Clinical Cancer Research · 138
An anti-CD6 monoclonal antibody (itolizumab) reduces circulating IL-6 in severe COVID-19 elderly patients
2020 · Danay Saavedra, Ana Laura Añé-Kourí, et al. · Immunity & Ageing · 34
PDF
Use of a Humanized Anti-CD6 Monoclonal Antibody (Itolizumab) in Elderly Patients with Moderate COVID-19
2020 · Yayquier Díaz, Mayra Ramos-Suzarte, et al. · Gerontology · 34
PDF
Treatment of COVID‐19 patients with the anti‐CD6 antibody itolizumab
2020 · Armando Caballero, Lázaro M Filgueira, et al. · Clinical & Translational Immunology · 22
PDF
An Anti-CD6 Antibody for the Treatment of COVID-19 Patients with Cytokine-Release Syndrome: Report of Three Cases
2021 · Lázaro Manuel Filgueira, Julio Betancourt Cervantes, et al. · Immunotherapy · 12
PDF
Superior Efficacy and Safety of a Nonemulsive Variant of the NGcGM3/VSSP Vaccine in Advanced Breast Cancer Patients
2016 · Ana de la Torre, Kirenia Pérez, et al. · Breast Cancer Basic and Clinical Research · 8
Nimotuzumab in Advanced Cervical Cancer: Safety and Efficacy Profile
2019 · Lorente Raiza Ruiz, Alfonso Sayly, et al. · International Journal of Oncology Research · 3
PDF
P2.40: CIMAvaxEGF Vaccine for the Treatment of Real-World NSCLC Patients
2016 · Maurenis Hernandez, Ramon A. Ortiz, et al. · Journal of Thoracic Oncology · 3
Real-World Effectiveness of Racotumomab as Maintenance Therapy in Advanced Non-Small Cell Lung Cancer Patients
2025 · Sailyn Alfonso Alemán, Haslen Cáceres Lavernia, et al. · Vaccines · 2
PDF
Supplementary Table 3 from A Randomized, Multicenter, Placebo-Controlled Clinical Trial of Racotumomab-Alum Vaccine as Switch Maintenance Therapy in Advanced Non–Small Cell Lung Cancer Patients
2023 · Sailyn Alfonso, Anet Valdés-Zayas, et al.
PDF
Supplementary Table 4 from A Randomized, Multicenter, Placebo-Controlled Clinical Trial of Racotumomab-Alum Vaccine as Switch Maintenance Therapy in Advanced Non–Small Cell Lung Cancer Patients
2023 · Sailyn Alfonso, Anet Valdés-Zayas, et al.
Supplementary Figure Legends from A Randomized, Multicenter, Placebo-Controlled Clinical Trial of Racotumomab-Alum Vaccine as Switch Maintenance Therapy in Advanced Non–Small Cell Lung Cancer Patients
2023 · Sailyn Alfonso, Anet Valdés-Zayas, et al.
PDF
Supplementary Figure 1 from A Randomized, Multicenter, Placebo-Controlled Clinical Trial of Racotumomab-Alum Vaccine as Switch Maintenance Therapy in Advanced Non–Small Cell Lung Cancer Patients
2023 · Sailyn Alfonso, Anet Valdés-Zayas, et al.
Supplementary Table 5 from A Randomized, Multicenter, Placebo-Controlled Clinical Trial of Racotumomab-Alum Vaccine as Switch Maintenance Therapy in Advanced Non–Small Cell Lung Cancer Patients
2023 · Sailyn Alfonso, Anet Valdés-Zayas, et al.
PDF
Supplementary Table 1 from A Randomized, Multicenter, Placebo-Controlled Clinical Trial of Racotumomab-Alum Vaccine as Switch Maintenance Therapy in Advanced Non–Small Cell Lung Cancer Patients
2023 · Sailyn Alfonso, Anet Valdés-Zayas, et al.
Supplementary Figure 2 from A Randomized, Multicenter, Placebo-Controlled Clinical Trial of Racotumomab-Alum Vaccine as Switch Maintenance Therapy in Advanced Non–Small Cell Lung Cancer Patients
2023 · Sailyn Alfonso, Anet Valdés-Zayas, et al.
PDF
Supplementary Table 2 from A Randomized, Multicenter, Placebo-Controlled Clinical Trial of Racotumomab-Alum Vaccine as Switch Maintenance Therapy in Advanced Non–Small Cell Lung Cancer Patients
2023 · Sailyn Alfonso, Anet Valdés-Zayas, et al.
PDF
Data from A Randomized, Multicenter, Placebo-Controlled Clinical Trial of Racotumomab-Alum Vaccine as Switch Maintenance Therapy in Advanced Non–Small Cell Lung Cancer Patients
2023 · Sailyn Alfonso, Anet Valdés-Zayas, et al.
Data from A Randomized, Multicenter, Placebo-Controlled Clinical Trial of Racotumomab-Alum Vaccine as Switch Maintenance Therapy in Advanced Non–Small Cell Lung Cancer Patients
2023 · Sailyn Alfonso, Anet Valdés-Zayas, et al.
Supplementary Table 3 from A Randomized, Multicenter, Placebo-Controlled Clinical Trial of Racotumomab-Alum Vaccine as Switch Maintenance Therapy in Advanced Non–Small Cell Lung Cancer Patients
2023 · Sailyn Alfonso, Anet Valdés-Zayas, et al.
Treatment of Systemic Inflammation with Itolizumab: A Single Center Experience
2022 · Lazaro M Filgueira, Armando Caballero, et al. · Archives of Clinical and Medical Case Reports
Immune Response in Patients Diagnosed with Non-Muscle Invasive Bladder Cancer Treated with CIMAvax-EGF Concomitant with Intravesical Bacillus Calmette-Guerin
2020 · Jenysbel de la Caridad Hernández, Laura Martínez, et al. · Journal of Cancer Science and Clinical Therapeutics
Sistema documental para la conducción de ensayos clínicos oncológicos en la atención primaria de salud
2018 · Geidy Lorenzo Monteagudo, Olga Torres Gemeil, et al.
Use of Nimotuzumab in The Treatment of Locally Advanced Esophageal Cancer in Real World
2016 · Y Saumell, L Sánchez, et al. · Value in Health
Racotumomab-Alum Vaccine for Maintenance Treatment of Recurrent Platinum-Sensitive Epithelial Ovarian Cancer Patients
2014 · M. Hernandez, S. Alfonso, et al. · Annals of Oncology
Works count: 25
Citation count: 256
H-index: 6
I10-index: 5
Year
Topic
Type